Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 90-95, January 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaminskas, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaminskas, E.

Inhibition of Sugar Uptake by Methotrexate in Cultured Ehrlich Ascites Carcinoma Cells1

Edvardas Kaminskas2

Department of Medicine, University of Wisconsin-Mount Sinai Medical Center, Milwaukee, Wisconsin 53201

Methotrexate (MTX) decreases adenosine 5'-triphosphate pools and inhibits glycolysis in cultured Ehrlich ascites carcinoma cells. The purpose of this study was to examine the effects of MTX on sugar transport and phosphorylation. Cells that were grown in continuous spinner cultures were incubated in media with and without 2 x 10-6 M MTX for 24 hr and assayed at intervals for rates of uptake of 3-O-methyl-D-glucose (to measure the rates of sugar transport), of 2-deoxy-D-glucose (to measure the rates of sugar transport and phosphorylation), and of glucose into total cellular material (to compare with the data obtained with the non-metabolizable sugars). MTX progressively and profoundly inhibited 2-deoxy-D-glucose uptake; the effect was on the Vmax and the apparent Km for 2-deoxy-D-glucose was normal. Adenosine 5'-triphosphate depletion by glucose deprivation inhibited 2-deoxy-D-glucose uptake to a similar degree. MTX progressively inhibited the rates of protein synthesis. Hexokinase activity in cell extracts was normal during first 6 hr and decreased after 24 hr. Cycloheximide progressively decreased 2-deoxy-D-glucose uptake rates, which corresponded to the decreases of hexokinase activity in cell extracts. Rates of 3-O-methyl-D-glucose transport were decreased by up to 50% in MTX-treated and in adenosine 5'-triphosphate-depleted cells. This decrease was not due to a change in the saturability characteristics of the transport system, to inhibition of protein synthesis, or to effects on a ouabain-sensitive adenosine-5'-triphosphatase. Hypoxanthine prevented the inhibitions of 3-O-methyl-D-glucose and of 2-deoxy-D-glucose uptakes by MTX. Glucose uptakes into total cellular material were reduced by 50% in cells incubated with MTX for 24 hr, by 30% in cells incubated with cycloheximide for 24 hr, and by 30% in glucose-deprived cells.

1 Supported by Mount Sinai Medical Center-University of Wisconsin Affiliation Program.

2 To whom requests for reprints should be addressed, at Mount Sinai Medical Center, P. O. Box 342, Milwaukee, Wis. 53201.

Received 6/26/78. Accepted 9/26/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.